Roskilde, Region Sjælland, Danmark
Kontaktoplysninger
296 følgere
291 forbindelser
Om
Aktivitet
-
Sanne Tavares is part of the original team hired at FÆRM back in the summer of 2021, at the same time as Head of Research Martina Moberger Weibull…
Sanne Tavares is part of the original team hired at FÆRM back in the summer of 2021, at the same time as Head of Research Martina Moberger Weibull…
Signe Vedel Borchert synes godt om dette
-
📢We are hiring! We are looking to strengthen our team with two individuals passionate about clinical development and experienced in supporting…
📢We are hiring! We are looking to strengthen our team with two individuals passionate about clinical development and experienced in supporting…
Signe Vedel Borchert synes godt om dette
-
🚀🔥 Få 50% rabat hele april! 🔥🚀 Er du klar til at starte din rejse mod at blive smertefri eller blive lige så stærk som en okse? Så har du…
🚀🔥 Få 50% rabat hele april! 🔥🚀 Er du klar til at starte din rejse mod at blive smertefri eller blive lige så stærk som en okse? Så har du…
Signe Vedel Borchert synes godt om dette
Erfaring og uddannelse
-
Calluna Pharma
Se al Signe Vedels erfaring
Se titel, ansættelsestid m.m.
eller
Flere aktiviteter af Signe Vedel
-
Today, on World Kidney Day, we aim to raise awareness about Chronic Kidney Disease (CKD), impacting over 850 million people globally and leading to…
Today, on World Kidney Day, we aim to raise awareness about Chronic Kidney Disease (CKD), impacting over 850 million people globally and leading to…
Signe Vedel Borchert synes godt om dette
-
Calluna Pharma is attending #BioEuropeSpring, March 18-20! Our CEO, John Montana, and Chief Medical Officer & Co-Founder, Jonas Hallén, are going…
Calluna Pharma is attending #BioEuropeSpring, March 18-20! Our CEO, John Montana, and Chief Medical Officer & Co-Founder, Jonas Hallén, are going…
Signe Vedel Borchert synes godt om dette
-
ShareLab member Arxx Therapeutics today announced the merger with Oxitope Pharma. The merged company, named Calluna Pharma, raises EUR 75 million…
ShareLab member Arxx Therapeutics today announced the merger with Oxitope Pharma. The merged company, named Calluna Pharma, raises EUR 75 million…
Signe Vedel Borchert synes godt om dette
-
We're kicking off the new year with exciting news - Arxx Therapeutics and Oxitope Pharma have merged to form Calluna Pharma. I am proud and eager to…
We're kicking off the new year with exciting news - Arxx Therapeutics and Oxitope Pharma have merged to form Calluna Pharma. I am proud and eager to…
Delt af Signe Vedel Borchert
-
Arxx Therapeutics, Jörg Klingelhöfer and Signe Vedel Borchert this is amazing :-) 75 million Euro that is a lot of money, what a great news. You…
Arxx Therapeutics, Jörg Klingelhöfer and Signe Vedel Borchert this is amazing :-) 75 million Euro that is a lot of money, what a great news. You…
Signe Vedel Borchert synes godt om dette
-
Oxitope Pharma and Arxx Therapeutics announce merger to form Calluna Pharma Inc.; and Calluna has raised a €75m Series A Financing…
Oxitope Pharma and Arxx Therapeutics announce merger to form Calluna Pharma Inc.; and Calluna has raised a €75m Series A Financing…
Signe Vedel Borchert synes godt om dette
Andre lignende profiler
-
Berte Poulsson
VP Operations, Calluna Pharma
Opret forbindelse -
Gunhild Klarskov Kristiansen
Owner and Senior Advisor at CMC Value Advisory
Opret forbindelse -
Luis Meneses
Project Engineer at IST/IPFN
Opret forbindelse -
Wenche Stensen
Senior Scientist at Amicoat AS
Opret forbindelse -
Christin Klös
Regulatory Affairs Officer / Konsulent
Opret forbindelse -
Øystein Lie
Co Founder hos TempoGene
Opret forbindelse -
Thales Menezes de Oliveira
Physics Ph.D Student at Brazilian Center for Physics Research
Opret forbindelse -
Jacob Nepper-Davidsen
Postdoc at Roskilde University - PhD in biology and biochemistry
Opret forbindelse -
Christina Villumsen
Senior Data Scientist / Engineer
Opret forbindelse -
Ellyn Sharkey
Associate Director at AstraZeneca
Opret forbindelse